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Abstract: Heart rate variability (HRV) reﬂ  ects both cardiac autonomic function and risk 
of arrhythmic death (AD). Reduced indices of HRV based on linear stochastic models are 
independent risk factors for AD in post-myocardial infarct cohorts. Indices based on nonlinear 
deterministic models have a signiﬁ  cantly higher sensitivity and speciﬁ  city for predicting AD 
in retrospective data. A need exists for nonlinear analytic software easily used by a medical 
technician. In the current study, an automated nonlinear algorithm, the time-dependent point 
correlation dimension (PD2i), was evaluated. The electrocardiogram (ECG) data were provided 
through an National Institutes of Health-sponsored internet archive (PhysioBank) and consisted 
of all 22 malignant arrhythmia ECG ﬁ  les (VF/VT) and 22 randomly selected arrhythmia ﬁ  les 
as the controls. The results were blindly calculated by automated software (Vicor 2.0, Vicor 
Technologies, Inc., Boca Raton, FL) and showed all analyzable VF/VT ﬁ  les had PD2i   1.4 and 
all analyzable controls had PD2i   1.4. Five VF/VT and six controls were excluded because 
surrogate testing showed the RR-intervals to contain noise, possibly resulting from the low 
digitization rate of the ECGs. The sensitivity was 100%, speciﬁ  city 85%, relative risk   100; 
p   0.01, power   90%. Thus, automated heartbeat analysis by the time-dependent nonlinear 
PD2i-algorithm can accurately stratify risk of AD in public data made available for competitive 
testing of algorithms.
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Brain and behavior have been shown in animal studies to be important variables in the 
initiation of ventricular ﬁ  brillation (VF) and its consequence, arrhythmic death (AD) 
(Skinner and Reed 1981; Skinner and Verrier 1982; Skinner et al 1983). The analysis 
of heart rate variability (HRV), which noninvasively provides real-time trending of 
beat-to-beat changes in the clinical ECG, reﬂ  ects covariations in autonomic func-
tion and later occurrences of VF (Akselrod et al 1981; Stein et al 1994). Decreased 
HRV indices are frequently found among patients with myocardial infarction (MI), 
congestive heart failure (CHF), diabetes, and alcoholic cardiomyopathy (Kleiger 
et al 1987; Stein et al 1994). The indices are independent risk factors for mortality 
in the post-MI and advanced CHF patients (Kleiger et al 1987; Coumel et al 1991; 
Stein et al 1994; Ho et al 1997). HRV indices based on brief observational windows 
(10- to 15-min) have the same predictability for VF and AD as those based on 24-hr 
records (Fei et al 1996).
The various HRV indices have not been widely adopted because no single measure-
ment has yet demonstrated sufﬁ  cient statistical predictability of AD in individuals, ie, 
they have inadequate sensitivity and speciﬁ  city to be of any clinical utility. The limited 
performance may be related to assumptions of the model underlying the algorithm Therapeutics and Clinical Risk Management 2008:4(2) 550
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used to measure the beat-to-beat variation. For example, an 
algorithm such as SDNN, which is based on a linear stochastic 
model, presumes the data variation is random, is distributed 
around a mean, and has had removed all arrhythmias, move-
ment artifacts and heart rate changes caused by uncontrolled 
nonstationary events. We know, however, that heartbeat 
intervals have brief internal correlations, are not random, 
and thus violate the model assumptions for most algorithms. 
In contrast, an algorithm based on a nonlinear deterministic 
model presumes that the variation is caused physiologically 
and has no beat-to-beat errors. Thus, the nonlinear measures 
should be inherently more accurate because the data ﬁ  t the 
underlying models, and apparently this is the case (Ho et al 
1997; Skinner et al 1998).
The consideration about the fundamental nature of the 
cardiac rhythm and its measurement has stimulated the devel-
opment of new HRV analyses (Wagner and Persson, 1998), 
but has left the clinical utility an open issue. Comparative 
tests among algorithms in retrospective data suggest that 
the time-dependent nonlinear algorithms show the greatest 
promise for clinical HRV analyses (Braun et al 1998; Skinner 
et al 1998; Marwan et al 2002).
Our objective was to evaluate the ability of a nonlin-
ear algorithm that is completely automated (Vicor 2.0, 
Vicor Technologies, Inc., Boca Raton, FL) and easy for a 
medical technician to apply to standard ECGs containing 
arrhythmias, artifacts, and other nonstationarities. This 
algorithm, the point correlation dimension (PD2i), was 
selected because of its insensitivity to nonstationarities in 
ECG data (Skinner et al 1993) and its superior performance 
compared with other linear and nonlinear algorithms in 
the prediction of documented lethal arrhythmogenesis 
(Skinner et al 1998). We used digitized ECGs posted in 
a public database, PhysioBank (Goldberger et al 2000). 
These ECGs have been made available for competitive 
testing of HRV algorithms. All 22 ﬁ  les from patients with 
malignant arrhythmias (ventricular ﬁ  brillation [VF] or 
sustained ventricular tachycardia [VT]) were selected and, 
as the controls, 22 randomly selected ﬁ  les with arrhythmias 
(common premature atria and ventricular contractions, and 




The clinical data were from the MIT-BIH (Harvard’s 
Beth Israel Hospital ECG Archive) contributions to the 
National Institutes of Health (NIH)-sponsored PhysioBank 
(Goldberger et al 2000), and included all of the malignant 
ventricular arrhythmia ECGs (n = 22), and a random selec-
tion of the arrhythmia ECGs (n = 22) to serve as the con-
trols. Half of the controls were randomly selected from the 
arrhythmia archive of over 4,000 ECGs (ﬁ  lenames 100–124) 
with common arrhythmia types (premature atrial and ven-
tricular beats) and the other half from the arrhythmia archive 
containing less common, but challenging arrhythmias (ﬁ  le-
names 200–234). The latter included; those with complex 
ventricular, junctional, and supraventricular arrhythmias 
that were thought to present signiﬁ  cant difﬁ  culty for algo-
rithmic processing. Documentation of the arrhythmia rates 
and types are provided in the PhysioBank, along with some 
relevant clinical data.
All ECGs were digitized at either 250-Hz (malignant 
ventricular arrhythmias) or 360-Hz (arrhythmias) and were 
approximately 20 to 30 minutes in length. Either VF or VT 
could be seen in the malignant arrhythmia ECGs, except 
in a few cases where documentation occurred within a few 
seconds to minutes after the ECG ﬁ  le ended. There were 
25 men and 32 women in the arrhythmia archive; the gen-
der for the malignant ventricular arrhythmia archive was 
unknown. The malignant arrhythmia ECGs were collected 
during the period from 1975 to 1979.
Pd2i analyses
All analyses were performed using completely blinded 
and automated procedures. The ﬁ  les were downloaded, 
renamed with a code name, and then sent to another site to 
be analyzed by a person without knowledge of their origin 
or outcome. The software (Vicor 2.0, Vicor Technologies, 
Inc.) ran in a completely automated fashion once the input 
ECG ﬁ  le name and its start and stop times were provided. 
Episodes of VF or VT were not included in the analyses. A 
common rule was used for determining the minimum number 
of data points (Ni) to resolve a given dimension (Kostelich 
and Swinney 1989). Successful time-dependent tracking of 
degrees of freedom (dimension) in ECG data with numerous 
arrhythmias and artifacts has been previously demonstrated 
for the PD2i algorithm (Skinner et al 1993). The same PD2i 
parameters were used in Vicor 2.0 as in previous publica-
tions (Tau = 1, LC = 0.30, CC = 0.40, PL = 0.15, PI = 4) 
(Skinner et al 1991, 1993, 1994, 1998, 2000; Vybiral and 
Skinner 1993; Elbert et al 1994; Skinner and Molnar 1999). 
Outliers greater than 2.8 standard deviations from the mean 
were removed from the relative risk-interval series by a linear 
interpolation spline, but only if PD2i scores less than 1.4 
were associated with them in time; this was done because Therapeutics and Clinical Risk Management 2008:4(2) 551
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large amplitude arrhythmias or artifacts of constant size can 
achieve low-dimensional PD2i scores; otherwise artifacts 
and arrhythmias are generally rejected from analysis by 
the LC and CC criteria in the PD2i algorithm (Skinner et al 
1993). The PD2i is insensitive to nonstationarities in the 
data (Skinner et al 1994), so no attempt was made to search 
for stationary sub-epochs upon which to perform the PD2i 
analyses.
Noise analyses
Relative risk (RR)-interval data contain descretization errors 
(0.8% for 250-Hz digitization of the ECG) and ampliﬁ  er 
noise (2 microvolts, 0.5%). They also contain RR-interval 
detection error compared with the visual standard; the 3-point 
running-window operator employed by Vicor 2.0, is set at 60 
msec between points and this template-matching is accurate 
within ±1 msec (0.1% error). A small amount of noise in the 
RR data is tolerated by the PD2i algorithm (ie, ± 5 integers; 
1 mV = 1 int; 0.7%) (Skinner et al 1994). So the excess noise 
produced by the low digitization rate of the 250-Hz ECG may 
present a problem compared to previous studies in which 
1000-Hz digitization was employed (ie, 1000-Hz digitization 
produces only one-fourth the descretization error of 250-Hz). 
Therefore each RR-interval ﬁ  le was ﬁ  rst inspected for noise 
content by Vicor 2.0 to assure a valid interpretation of the 
nonlinear PD2i result. To assure that the data were not con-
taminated by noise, two tests were run, the more conventional 
Surrogate Test (Theiler et al 1992; Schreiber and Schmitz 
1996) and the %N Test used in our previous studies (Skinner 
et al 1991, 1993, 1994, 1998, 2000).
Statistical analysis
The sensitivity, specificity, and RR statistics assessed 
predictability, using Fisher’s Exact Test to determine the 
signiﬁ  cance of each true or false vs VF/VT or noVF/VT 
contingency (Prism Software, Irvine, CA). Powering of the 




The study utilized 44 ECGs, each of which had a known out-
come (22 VF/VT and 22 noVF/VT). The clinical data for each 
subject were not reported in the PhysioBank for the VF/VT 
subjects, but the peer-reviewed manuscript (Goldberger et al 
2000) declares that the archived ECGs are valid open source 
data to be used in determining algorithmic quantiﬁ  cations, 
such as those employed in this study.
Analytic results
Figure 1 shows data and analytic results from a normal 
healthy individual (A) and from two typical ECGs in the 
database (B and C). Figure 2 shows accepted PD2i values 
for 7 Arrhythmia controls and 7 VF/VT subjects. The PD2i 
of the VF/VT subjects all fall below the 1.4 level (horizontal 
bar). This 1.4 cut-point was a priori adopted from our ﬁ  rst 
published clinical study (Skinner et al 1993), as this criterion 
was based on receiver-operator curves to maximize sensitivity 
and speciﬁ  city. The primary results shown in Figure 2 for the 
ﬁ  rst half of the non-excluded subjects are virtually the same 
as those for the second half, as documented in Table 1.
Clinical prediction of arrhythmic death
Table 1 shows the results from all 44 subjects. The coded ﬁ  le 
names are in column 1 and the corresponding ﬁ  le names in 
the MIT-BIH database are in column 2. The column labeled 
PD2i Test indicates for each ECG ﬁ  le those with PD2i   1.4 
(POS), those with PD2i   1.4 (NEG) and those rejected 
(Rej) because of noise content (failed Surrogate Test, failed 
%N Test). The PD2i of the RR-intervals and the PD2i for 
the randomized-phase surrogates made from the RR intervals 
were not statistically signiﬁ  cantly different for 11 ECGs (Sur-
rogate Test, ns), and these cases were a priori exclusions from 
analysis. These same surrogate-excluded ﬁ  les showed %N to 
be less than 30%, and were thus automatically rejected by the 
Vicor 2.0 software (PD2i Test, Rej). The rejected ECG ﬁ  les 
included all cases of atrial ﬁ  brillation and high arrhythmia rate 
(ie,   10% of beats). The origin of the arrhythmias was of sinus, 
ventricular, or a mix of both. The VF/VT Outcomes (column 4) 
were expressed as true negative (TN), true positive (TP), false 
negative (FN), false positive (FP) or a priori excluded (Exc). Of 
the 33 nonrejected ﬁ  les, 17 were TP, 13 TN, 3 FP, and 0 FN. 
This resulted in a sensitivity = 100%, speciﬁ  city = 85%, posi-
tive predictive value = 85%, negative predictive value = 100%, 
and relative risk   100 (p   0.01, Fisher Exact Test). These 
were all sufﬁ  ciently powered tests (  90%). The hypothesis 
that the VF/VT predictions were by chance alone was rejected 
(p   0.001, Binomial Probability Test).
Discussion
Interpretation of results
The automated PD2i algorithm (Vicor 2.0) appears to work 
well on ECG data digitized at 250-Hz instead of the more 
usual 1000-Hz employed in previous studies (Skinner et al 
1993, 1994, 1998, 2000), but this lower digitization rate may 
contribute to the greater number of exclusions from analysis 
than previously observed (Skinner et al 1993) because of Therapeutics and Clinical Risk Management 2008:4(2) 552
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Figure 1 Relative risk (RR)-intervals and associated PD2i’s determined from the electrocardiogram (ECG) of a normal healthy person and two types of PhysioBank patients. 
A. Shows RR data and corresponding PD2i results from a normal healthy subject (15 min ECG). B. Shows results from an arrhythmia control patient (30 min ECG, PhysioBank). 
C. Shows results from a VF/VT patient (30 min ECG, PhysioBank). PD2i values are expressed in degrees of freedom (dimensions) and RR values in msec;   VF is included in the 
analysis for illustrative purposes only. Parts A-C each show 4 individual plots for comparing the data and the analytic results: upper left the RR-intervals (RRi), lower left the 
corresponding PD2i, upper right the joint plot of RRi and PD2i, lower right the histogram of the accepted PD2i values with its associated statistics, including %N. The ECG for 
the RRi shown in Part C. manifests VF at 17 minutes from the start and the PD2i before VF shows repeated low-dimensional excursions fall below 1.4 (line). The ECG shown 
in Part B. did not manifest any PD2i below 1.4 throughout the 30-min period. The test result indicated in the upper right plot (underlined) was completely automated by the 
Vicor 2.0 software once the input ﬁ  le was entered.Therapeutics and Clinical Risk Management 2008:4(2) 553
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Figure 2 PD2i traces from arrhythmia controls and malignant arrhythmia subjects for the ﬁ  rst half of the data set. PD2i values are expressed in degrees of freedom (dimen-
sions) and the heartbeats are those obtained in a 15- to 30-min ECG up to the end or point of VF/VT onset. Note the low-dimensional excursions of the PD2i in the VF/VT 
subjects. The horizontal a priori criterion lines are set at 1.4 degrees of freedom and completely separate the two groups of patients. The rejected PD2i points are due to 
noise produced by arrhythmias and movement artifacts, but %N remains high enough in these patients for valid analysis. Surrogate- and %N-rejected ﬁ  les (n = 11) are not 
shown as they were a priori rejected (5 VF/VT, 6 controls). These rejected ﬁ  les contained all subjects with atrial ﬁ  brillation and the highest arrhythmia rates (ie, greater than 
10% arrhythmias in all beats).Therapeutics and Clinical Risk Management 2008:4(2) 554
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the higher descretization error. All of the other sources of 
noise (high arrhythmia rate, movement artifacts, ampliﬁ  er 
noise) are additive with the descretization error and together 
determine the number of failed Surrogate Tests and %N 
Tests. The PD2i of the heartbeats in publicly archived ECGs 
is a statistically signiﬁ  cant predictor of VF/VT, with there 
being no FN cases, and thus conﬁ  rms previous observations 
in retrospective data that did not employ automated analyses 
Table 1 PD2i of heartbeats predicts VF/VT in PhysioBank ECGsa
Coded ﬁ  le  MIT -BIH  PD2i test  VF/VT outcome*  Surrogate test  %N test
1 100  NEG  TN  p    0.01  86
2 422  POS  TP  p    0.01  50
3 419  POS  TP  p    0.01  32
4 107  NEG  TN  p    0.01  92
5 200  Rej  Exc  ns  17
6 424  Rej  Exc  ns  22
7 611  POS  TP  p    0.01  78
8 114  NEG  TN  p   0.01 67
9 430  POS  TP  p    0.01  31
10 426  POS  TP  p    0.01  41
11 119  Rej  Exc  ns  23
12 602  POS  TP  p    0.01  33
13 607  POS  TP  p    0.01  60
14 228  NEG  TN  p    0.01  37
15 425  Rej  Exc  ns  23
16 104  NEG  TN  p    0.01  68
17 418  POS  TP  p    0.01  36
18 428  POS  TP  p    0.01  87
19 101  NEG  TN  p    0.01  64
20 421  POS  TP  p    0.01  67
21 420  POS  TP  p    0.01  76
22 106  NEG  TN  p    0.01  33
23 121  NEG  TN  p    0.01  81
24 610  POS  TP  p    0.01  33
25 605  Rej  Exc  ns  27
26 231  POS  FP  p    0.01  54
27 217  NEG  TN  p    0.01  61
28 201  Rej  Exc  ns  13
29 423  POS  TP  p    0.01  33
30 429  POS  TP  p    0.01  38
31 113  NEG  TN  p    0.01  39
32 116  POS  FP  p    0.01  92
33 203  Rej  Exc  Ns  22
34 124  NEG  TN  p    0.01  52
35 427  POS  TP  p    0.01  68
36 612  POS  TP  p    0.01 46
37 614  Rej  Esc  ns  23
38 221  Rej  Exc  ns  11
39 213  Rej  Exc  ns  3
40 615  Rej  Exc  ns  17
41 223  NEG  TN  p    0.01 70
42 233  POS  FP  p    0.01 33
43 609  POS  TP  p    0.01 45
44 103  NEG  TN  p    0.01 82
Notes: Sensitivity = 100%; speciﬁ  city = 85%; p   0.01 (Fisher Exact); Coded File: coded ﬁ  le names, as shown in Figure 2, to cross reference with PhysioBank ﬁ  le names; MIT-BIH, 
PhysioBank ﬁ  le names for the ECG data (ie, from MIT and Beth Israel Hospital archives); PD2i Test, analytic result, where NEG (negative) indicates PD2i   1.4, POS (positive) 
indicates PD2i   1.4, and Rej (rejection) indicates data rejected by the %N criterion; all analytic results were automated by the Vicor 2.0 software;   VF/VT Outcome, given the 
VF/VT or no VF/VT outcome by PhysioBank, the PD2i predicted a True Negative (TN), a True Positive (TP), a False Negative (FN; none indicated), or a False Positive (FP); Exc 
indicates the prediction could not be made because the Surrogate and %N Tests together could not afﬁ  rm that the data were noise-free; Surrogate Test, probability that the 
mean PD2i of the data and the mean PD2i of the randomized-phase surrogate were the same, as tested by a 2-tailed t-test; ns indicates they were not statistically signiﬁ  cantly 
different, and therefore the data could not be presumed to be noise-free; %N Test, % of accepted PD2i values, where values less than 30 lead to rejection of the data by the 
Vicor 2.0 software for a valid PD2i analysis.Therapeutics and Clinical Risk Management 2008:4(2) 555
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(Skinner et al 1993, 1998). The comparison of results sug-
gests that PD2i analysis of the ECG by a technician using 
the Vicor 2.0 software is equal to that by an expert in non-
linear signal analysis doing all of the analytic operations 
by hand.
What the PD2i measures
There can be little doubt that cardiac vulnerability to lethal 
arrhythmogenesis is regulated by the brain and autonomic 
nervous system, for blockade of the descending efferent 
pathways, at the level of the frontal cortex (Skinner and Reed 
1981) or amygdala (Carpeggiani et al 1992) or at the level of 
the peripheral cardiac nerves (Ebert et al 1970), will prevent 
VF in animals following coronary artery occlusion. These 
higher neural systems also participate in the regulation of 
the heart rate, just as do the afferent-efferent loops through 
the medulla that underlie the baroreﬂ  ex and respiratory sinus 
arrhythmia and the loops through the hypothalamus that 
regulate blood pH and temperature.
During quiet wakefulness each of these multiple loops 
contributes to the nonlinear regulation of the RR-intervals 
by its interaction on its own time scale (Marwan et al 2002; 
Braun et al 1998). The degrees of freedom resulting from the 
net nonlinear interactions are approximately 6, ranging in time 
from 4 to 8 (Figure 1A). This type of tied-together regula-
tion results in the erratic RR-interval series that is clinically 
referred as the “normal sinus rhythm.” It is the physiological 
evolution of abnormal dynamics in this tied-together, nonlin-
ear regulation that leads to the type of altered rhythm that is 
associated with susceptibility to VF in hospitalized patients. 
Such a dynamic is associated with a reduction in the number 
of degrees of freedom, as shown in Figures 1 and 2. This 
reduction in the degrees of freedom in the heartbeats below 
1.4 could result from greater “cooperation” or phase relation-
ship among the independent regulators. We do not yet know 
how this or any alternative mechanisms may actually produce 
the changed dynamics, but we do know it is organized by the 
higher nervous system (Meyer et al 1996; Skinner 2007).
The PD2i algorithm is a new measure of heartbeat regula-
tion that, instead of being based on a linear stochastic model 
like the standard deviation and power spectra, is a nonlinear 
measure of variability not requiring any a priori presumptions 
about the data in its underlying model. The motivation for 
developing the PD2i algorithm was the simple observation 
that the series of heartbeat intervals is not a sequence of inde-
pendent numbers randomly distributed around a mean, as is 
required by any algorithm based on a linear stochastic model. 
An indepth discussion of these fundamental issues (“When 
the mean is meaningless”), along with the presentation of 
other novel nonlinear algorithms in the assessment of HRV, 
is provided elsewhere (Braun et al 1998; Stiedl and Meyer 
2002, 2003). The poorer performance of the linear measures, 
we believe, results from the fundamental misconception that 
analyzing an inherently nonlinear and correlated time series 
by a linear stochastic technique is all right. On theoretical 
grounds this usage commits a serious type-II error.
The PD2i measures the degree of interaction, or “coopera-
tion,” among the competing neural loops that simultaneously 
control the dynamics of the cardiac rhythm and the vulner-
ability of the heart to lethal arrhythmogenesis. Accentuated 
cooperation or breakdown of the normal coupling among 
these competing autonomic nervous loops (ie, PD2i   1.4) 
is somehow able to set the stage for the evolution of lethal 
arrhythmogenesis. The mechanism for the coordination of 
such “cooperation” is presently unknown, but there can 
be little doubt that it is organized within the brain and is 
projected onto the nodal and ventricular tissues of the heart 
through the autonomic nervous system. The heart trans-
plant recipient manifests a resting heartbeat dynamics of 
PD2i = 1.0, because there is only the one intrinsic cardiac 
regulator intact (Meyer et al 1996). This denervation result 
also indicates that the nervous system must produce the 
higher degrees of freedom found in the normal subject. 
Besides denervation, lowering of the heartbeat PD2i can also 
be achieved by blockade of the NMDA receptors, which are 
the synaptic mediators in virtually all of the cardiovascular 
centers in the brain (Skinner et al 2000).
Comparison of PD2i with TWA
Although no head-to-head comparison of PD2i and TWA has 
yet been made to establish their relative clinical utility, it is 
worth noting a comparison between them. Recently, T-wave 
alternans (TWA), detected by a heart-rate dependent algo-
rithm that measures the small repolarization ﬂ  uctuations of 
the T-wave, has shown high predictability of arrhythmic 
death in high-risk patients (Kop et al 2004). This method 
requires a stable ECG (data stationarity) of a high heart rate 
(treadmill) and low-noise in the ECG (special electrodes), 
and it is therefore difﬁ  cult to apply to critically ill patients. 
The PD2i Test has none of these limitations.
When PD2i = 1.0, it indicates that the data have a 
dynamics called a limit-cycle, a dynamics which could be an 
alternating series of data like that the TWA device detects. 
At the higher heart rates TWA correlates with QT-intervals, 
at least in the high-risk patients (Janusek et al 2005), and 
thus TWA likely correlates with RR-intervals too, that is, as Therapeutics and Clinical Risk Management 2008:4(2) 556
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very little rate-dependent adjustments between QT and RR 
occur at the higher heart rates. PD2i values slightly above or 
below the singular value of 1.0, however, do not alternate, 
but rather they have a chaotic variation and look noisy, but 
they are not noise because they have a low dimension. It 
may be the case that TWA, which detects small alternating 
changes in repolarization, can detect the same patients where 
PD2i = 1.0. But conversely, TWA could not be expected to 
detect the same patients at risk of VF/VT where PD2i is not 
equal to 1.0.
Conclusions
We conclude that a rapid, automated, and cost-effective 
assessment of risk of VF/VT can be made for patient ECGs 
archived by NIH in a public data base. Only a 15–30 min 
sample of ECG data is required for an immediate assess-
ment of the nonlinear RR-intervals by the PD2i algorithm, 
as embodied in the Vicor 2.0 software (ie, Ni  1,000 
heartbeats to meet the Ni  10PD2i criterion for PD2i   3.0; 
Kostelich and Swinney 1989). Once recorded, the data ﬁ  le 
can be examined for noise content by the PD2i acceptance 
ratio (%N) for a priori exclusion of patients with randomized 
RR-intervals resulting from noise contamination, atrial ﬁ  bril-
lation, or high arrhythmia rate ( 10% of beats). In this way, 
the RR-intervals that are not suitable for nonlinear analysis 
can be quickly detected and excluded. The present results in 
public ECG data show PD2i predictability of VF/VT within 
the same day. These results support our recent prospective 
study (Skinner 2007), in which PD2i prediction of arrhythmic 
death was found to extend from days to weeks and months in 
a cohort of 400 chest-pain patients with ECG abnormalities 
(Skinner 2007).
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